Swiss Venture Capital Report 2018: ADC Therapeutics ranks #1 in top 20 VC rounds in Switzerland for the second consecutive year, closing CHF 197 Million in 2017
After having raised the largest investment round for a Swiss startup in 2016 (CHF 104 Million), ADC Therapeutics ranks #1 again in the top 20 VC rounds in 2017 with 200 Million (raised in October 2017).
New record: Swiss startups have raised 938 Millions in total in 2017, CHF 595 Million for Life Sciences companies, far beyond ICT and other sectors like Cleantech or Consumer products.
And Vaud ranks #1 attracting 32% of the total investments for startups in Switzerland.
For more information: Read the latest Swiss Venture Capital Report 2018